• 1. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 2. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 3. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 4. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 5. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere

Introduction to Piperazine,1-[(8-chloro-2-naphthalenyl)sulfonyl]-, hydrochloride (1:1) and Its Significance in Modern Chemical Biology

Piperazine,1-[(8-chloro-2-naphthalenyl)sulfonyl]-, hydrochloride (1:1) (CAS No. 864759-58-0) is a sophisticated sulfonamide derivative that has garnered significant attention in the realm of chemical biology and pharmaceutical research. This compound, characterized by its unique structural motif—a piperazine ring conjugated with a chlorinated naphthalene sulfonamide moiety—has emerged as a promising candidate for various therapeutic applications. The hydrochloride salt form enhances its solubility, making it more amenable for biological assays and drug development processes.

The structural composition of Piperazine,1-[(8-chloro-2-naphthalenyl)sulfonyl]-, hydrochloride (1:1) imparts distinct pharmacological properties that make it particularly valuable in the design of novel bioactive molecules. The presence of the piperazine ring, a well-known pharmacophore in medicinal chemistry, contributes to its ability to interact with biological targets such as enzymes and receptors. Meanwhile, the sulfonamide group and the chlorinated naphthalene moiety enhance its binding affinity and selectivity, which are critical factors in drug discovery.

In recent years, sulfonamide derivatives have been extensively studied due to their broad spectrum of biological activities. Among these, Piperazine,1-[(8-chloro-2-naphthalenyl)sulfonyl]-, hydrochloride (1:1) has shown particular promise in the inhibition of various enzymatic pathways associated with inflammatory and infectious diseases. Its molecular framework allows for fine-tuning of pharmacokinetic properties, making it an attractive scaffold for structure-activity relationship (SAR) studies.

One of the most compelling aspects of Piperazine,1-[(8-chloro-2-naphthalenyl)sulfonyl]-, hydrochloride (1:1) is its potential application in modulating immune responses. Emerging research indicates that this compound can interact with key immune signaling pathways, potentially leading to novel therapeutic strategies for autoimmune disorders and chronic infections. The chloro-substituent on the naphthalene ring plays a crucial role in modulating these interactions by enhancing binding affinity to target proteins.

The hydrochloride salt form of this compound not only improves solubility but also ensures stability under various storage conditions. This makes Piperazine,1-[(8-chloro-2-naphthalenyl)sulfonyl]-, hydrochloride (1:1) a reliable reagent for both laboratory research and industrial-scale applications. Its compatibility with high-throughput screening (HTS) platforms further underscores its utility in drug discovery pipelines.

Recent advancements in computational chemistry have enabled more precise predictions of the biological activity of Piperazine,1-[(8-chloro-2-naphthalenyl)sulfonyl]-, hydrochloride (1:1). Molecular docking studies have revealed its potential binding interactions with proteins such as kinases and transcription factors, which are pivotal in numerous disease pathways. These insights have guided the optimization of synthetic routes to enhance its bioavailability and therapeutic efficacy.

The synthesis of Piperazine,1-[(8-chloro-2-naphthalenyl)sulfonyl]-, hydrochloride (1:1) involves multi-step organic reactions that require precise control over reaction conditions. Advanced catalytic methods have been employed to improve yield and purity, ensuring that researchers obtain high-quality material for their studies. The development of greener synthetic protocols aligns with the growing emphasis on sustainable chemistry practices in pharmaceutical manufacturing.

Preclinical studies have begun to explore the potential therapeutic applications of Piperazine,1-[(8-chloro-2-naphthalenyl)sulfonyl]-, hydrochloride (1:1) in models of inflammation and infection. Initial results are promising, suggesting that it may serve as a lead compound for further development into novel drugs. The compound's ability to modulate key biological pathways without significant off-target effects makes it an attractive candidate for clinical translation.

The future prospects for Piperazine,1-[(8-chloro-2-naphthalenyl)sulfonyl]-, hydrochloride (1:1) are vast. Ongoing research aims to elucidate its mechanism of action in greater detail and identify new therapeutic indications. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the development process from bench to bedside.

In conclusion,Piperazine, [ (8 - chloro - 2 - naphthalenyl) -sulfonyl -], hydrochloride ( 1 ? 1 ), CAS No. ?????? - ?? - ? is a multifaceted compound with significant potential in chemical biology and drug development. Its unique structural features and demonstrated biological activities position it as a valuable tool for researchers exploring new therapeutic strategies across multiple disease areas.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)